Dr Dayle Hogg

As Commercial Manager at Lectus Therapeutics Limited, Dayle plays a key role in developing strategic alliances and pursuing partnering/collaborative opportunities as well as securing commercial deals with service providers such as Evotec Limited. Dayle was part of the team that secured the strategic investment from Takeda Research Investment, the investment arm of Takeda Pharmaceutical Company, and also the recent ‘Series A’ financing for the company. Dayle also plays an important role in the evaluation of new commercial opportunities.

Previously Dayle worked within Business Development at Sense Proteomic Ltd, whose core business was the development and sale of functional protein array products.

Dayle received a BSc (Honours) degree in Pharmacology from the University of Leeds and a D. Phil. in Pharmacology from the University of Oxford. At a research level, Dayle trained as an electrophysiologist where his interests centred on the role of ion channels in regulating pulmonary blood flow.